✦ LIBER ✦

Treatment of severe depression with the selective serotonin reuptake inhibitors

✍ Scribed by Alan F. Schatzberg

Publisher: John Wiley and Sons
Year: 1996
Tongue: English
Weight: 120 KB
Volume: 4
Category: Article
ISSN: 1091-4269
DOI: 10.1002/(sici)1520-6394(1996)4:4<182::aid-da4>3.0.co;2-h

No coin nor oath required. For personal study only.

✦ Synopsis

The selective serotonin reuptake inhibitors (SSRIs) are recognized as effective as and better tolerated than older antidepressant therapies and have become the drugs of choice in the treatment of mild to moderate depression. However, there is a clinical impression that the SSRIs are less effective than older therapies in the severely depressed patient. A limited number of trials have attempted to address this issue. This review assesses 16 controlled studies of SSRIs in severe depression. The findings from a majority of studies found the SSRIs to be superior to placebo and as effective as but better tolerated than the tricyclic antidepressants (TCAs) in severely depressed patients. Although future studies are needed to corroborate and elaborate on these data, studies still support the use of SSRIs in this patient population.

📜 SIMILAR VOLUMES

Treatment of children With antidepressan

Treatment of children With antidepressants: Focus on selective serotonin reuptake inhibitors

✍ Graham J. Emslie; Warren A. Weinberg; Taryn L. Mayes 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 45 KB 👁 1 views

THE USE OF SELECTIVE SEROTONIN REUPTAKE

THE USE OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS FOR DEPRESSION AND PSYCHOSIS COMPLICATING DEMENTIA

✍ WILLIAM J. BURKE; VIJAY DEWAN; STEVEN P. WENGEL; WILLIAM H. ROCCAFORTE; GRACE C. 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB 👁 1 views

This retrospective chart review examines the impact of selective serotonin reuptake inhibitors on 20 patients with both depression and psychosis complicating dementia of the Alzheimer type (DAT) and other dementias. Fifteen of the 20 patients had moderate to marked improvement in depressive and psyc

Movement disorders and abuse potential o

Movement disorders and abuse potential of the selective serotonin reuptake inhibitors

✍ B. E. Leonard 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB 👁 1 views

A review of the safety of selective sero

A review of the safety of selective serotonin reuptake inhibitors during pregnancy

✍ David J. Goldstein; Karen Sundell 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 1 views

Antidepressant treatment may be desirable or necessary during pregnancy; however, the bene®t of treatment must balance the bene®ts to the mother with any risk to the developing fetus. In order to make educated, patient-speci®c, bene®t-to-risk assessments, an understanding of possible risks associate

Selective serotonin reuptake inhibitors

Selective serotonin reuptake inhibitors and withdrawal symptoms: a review of the literature

✍ François Therrien; John S. Markowitz 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB 👁 2 views

There are accumulating reports of withdrawal symptoms emerging following the discontinuation of selective serotonin reuptake inhibitor antidepressants. This report summarizes published reports, characterizes the withdrawal syndrome, discusses potential mechanisms of withdrawal, and makes recommendat

‘The use of selective serotonin reuptake

‘The use of selective serotonin reuptake inhibitors for depression and psychosis complicating dementia’—1997, 12, 519–527

✍ Brian Lawlor 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB 👁 1 views

serotonin syndrome may have been caused by the sum of the serotonergic eects of mirtazapine and ¯uoxetine. The serotonin syndrome appeared despite the concurrent use of chlopromazine, which, by blocking 5-HT1/5-HT2 receptors, was reported to treat it . The same mirtazapine, by blocking 5-HT2/5-HT3 r